Patrick Kenny, product marketing specialist for Thermo Fisher Scientific explains why the storage and access of chromatography data is vital to pharmaceutical manufacturing chains.
Chromatography data
Analytical workflows underpin many of the most essential processes in the pharmaceutical manufacturing chain, from the analysis of raw materials and final products, through to method development and validation checks. These workflows often involve gas or liquid chromatography techniques, coupled to robust detection methods such as mass spectrometry, which generate large volumes of data.
Organising, accessing and sharing the complex information generated by chromatography workflows can be challenging, particularly if production and quality control (QC) teams are located across multiple locations. With regulatory authorities putting increased focus on the accuracy, consistency and completeness of pharmaceutical manufacturing data, these workflows must be managed in a way that not only maximises operational efficiency and provides space to innovate, but supports full regulatory compliance too. As a consequence, many pharmaceutical organisations are re-evaluating the systems and methods they use to manage and control their chromatography data.